their architectural orientation. Dysplastic changes include pleomorphism, hyperchromatic nuclei, abnormally large cell size, abundant mitotic figure accumulation, and loss of progressive maturation of basal cells carcinoma. 1 Oral dysplasia has a significant transformation risk to oral squamous cell carcinoma. 2 In a recent meta-analysis, it was estimated that oral dysplasia has an overall 10.5% malignant transformation risk. 2 However, several studies showed a wide range (5%-27%) of transformation risks, mainly depending on dysplasia grade. [3] [4] [5] [6] It is believed that during malignant transformation, the dysplastic cells may escape from destruction mediated by the adaptive immune system. 7 Immune checkpoints refer to a group of molecules that induce immune tolerance, prevent induction of autoimmune diseases, and protect tissues from immune collateral damage. 8 Immune checkpoints are used by cancer cells to escape from immune cell destruction, mainly by CD8 + T cells and NK cells. 9 The presence of distinct immune checkpoint molecules, such as indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1) in tumors, are considered as negative prognostic factors. [10] [11] [12] Furthermore, immune checkpoint inhibitors, such as PD-1/PD-L1 axis inhibitors, are already in use as anticancer therapies. 13 Other immune checkpoint inhibitors, such as IDO1, are still in clinical trials.
14 IDO1 is a heme-containing enzyme that controls the immune system through several inhibitory pathways mediated by cell metabolism. 15 An increase in IDO1 expression leads to raised T-cell tolerance and promotes the differentiation of na€ ıve CD4 + T cells into regulatory T cells. 16 On the other hand, PD-L1, a ligand for programmed death receptor 1, can induce immune tolerance by reducing CD8 + T-cell proliferation and promoting functional T-cell exhaustion.
17
There are currently several studies on the immunohistological expression of immune checkpoint molecules in oral cancer.
11,18
However, less is known about the roles of these molecules in potentially malignant oral lesions. Therefore, the purpose of this study was to analyze the expression of IDO1 and PD-L1 in oral dysplasia; to investigate the possible association between these molecules, dysplasia grade, and the inflammatory cell infiltration; and to follow disease progression and the expression of these molecules over time in oral dysplasia samples.
| MATERIALS AND METHODS

| Patients and ethical approval
The study plan was approved by the Ethics Committee of the to confirm the quality of the staining (data not shown).
| Evaluation of staining and cell counting
A fully automated Leica DM6000 microscope together with a Leica DFC365-FX camera (Leica Microsystems) and a BX61
Motorized System Microscope (Olympus Life and Material Science Europa GmbH, Hamburg, Germany) were used to image the stained samples. 
| Statistical analyses
| RESULTS
| IDO1 expression is downregulated in dysplastic oral epithelium compared with healthy controls
In healthy controls, IDO1 was strongly expressed in all oral epithelial layers except the basal layer ( Figure 1D ). In the dysplastic oral epithelium, IDO1 was either weakly positive or negative ( Figure 1E ).
This difference was highly significant (P < .0001, Figure 1F ). In the lamina propria, IDO1 was similarly expressed in samples from patients with oral dysplasia and healthy controls (P > .05, data not shown). Within the same sample, the epithelium at the dysplasticfree area had higher IDO1 expression than that of the dysplastic epithelium (P = .004, Figure 1G , H). 
| Dysplasia grade is associated with IDO1 and PD-L1 expression levels and the amount of inflammatory cell infiltration
Dysplasia grade was negatively associated with epithelial IDO1 expression (Supplement A, Table 2 ) and positively with lamina propria IDO1- (Table 2 ) and PD-L1-positive cell count (Supplement B, Table 2 ). Dysplasia grade was also positively associated with inflammatory cell infiltration (Table 2) .
| IDO1 and PD-L1 expression does not correlate with patient characteristics
Dysplasia patients were categorized according to their age (≤50 and >50 years), gender, smoking status, site of the lesion (tongue and others), presence of lichenoid features, and presence of previous cancer. Neither IDO1 nor PD-L1 was associated with any of the studied categories, except PD-L1, which was expressed slightly more in the samples which have lichenoid features ( Table 2 ). The presence of lichenoid features was associated positively with inflammatory cell infiltration and dysplasia grade. Dysplasia grade was higher in male patients ( Table 2) .
| Dysplasia grade, inflammatory cell infiltration, and IDO1 and PD-L1 expression fluctuate over time
Eight patients were followed from 3 to 36 months with more than one biopsy taken. Dysplasia grade, inflammatory cell
infiltration, and IDO1 (in both the epithelium and lamina propria) and PD-L1 expression fluctuated over time (Figure 2 ).
No stable progression was detected in any of the studied criteria.
| DISCUSSION
This study revealed a significant association between oral epithelial dysplasia grade, inflammatory cell infiltration, and expression of F I G U R E 1 Significant decrease in IDO1 and increase in PD-L1 expression in the dysplastic samples compared with the healthy control. HE staining of the oral mucosa showing mild (A), moderate (B), and severe dysplasia (C). Healthy and dysplastic samples were immunostained for IDO1 and PD-L1. Healthy control epithelium was positive for IDO1 (D), while dysplastic epithelium was negative (E). IDO1 expression was significantly lower in the dysplastic epithelium than that in the healthy control (F). Eighteen samples showed both dysplastic and non-dysplastic areas in the same slide (G). For these cases, IDO1 expression was significantly higher in the non-dysplastic areas compared with the dysplastic areas (H). PD-L1 was negative in the epithelium and lamina propria of healthy control samples (I). In dysplastic samples, PD-L1 was negative in the oral epithelium and positive in the lamina propria (J, K). Scale bar = 100 lm. **P ≤ .01, ****P ≤ .0001
immune checkpoint molecules (IDO1 and PD-L1). Interestingly, these associations were either positive or negative depending on the molecules studied and the site of its expression (epithelium or lamina propria). Additionally, dysplasia grade, inflammatory cell infiltration, and expression of immune checkpoint molecules fluctuated over time.
We found that IDO1 is strongly expressed in healthy control epithelium compared with dysplastic lesions. The same phenomenon was present in samples with dysplastic and non-dysplastic areas, which supports our previous observation. Even though IDO1 expression is induced in oral cancer, 5 we were surprised to observe the opposite in dysplastic oral epithelium. This could possibly be the reason behind the loss of immune tolerance in the dysplastic oral epithelium, 20 as IDO1 plays an important role in inducing immune tolerance. Immune tolerance is known to be essential in the oral mucosa due to the presence of a large number of different microbes in the oral cavity. 21, 22 Loss of immune tolerance could result in activation of the immune system and infiltration of inflammatory cells. 23 Such phenomena are indeed occurring in oral dysplasia as this study found that dysplasia grade was positively associated with inflammatory cell infiltration, even though oral dysplasia is not an infectious disease. On the other hand, IDO1 expression in the lamina propria was enhanced with increase in dysplasia grade, which may be caused by associated inflammation and the production of pro-inflammatory cytokines. 24 In contrast to the expression of PD-L1 in cancer cells of oral squamous cell carcinoma, [25] [26] [27] in our study, PD-L1 was negative in the oral epithelium of both healthy control and dysplasia samples. In This observation should be interpreted with caution, as most of the studied cases were clinically suspicious for cancer. In our samples, male patients had on average a higher oral dysplasia grade, which is associated with a greater risk of malignant transformation. In contrast, studies on other populations have shown that dysplasia in females more often transform to cancer. 29 The explanation for our finding could be due to several factors, including hormones and male lifestyle, such as smoking. Although 40% of males and only 10% of the females were smokers (data not shown), we did not find T A B L E 2 Association between dysplasia grade, inflammatory cell infiltration, IDO1 and PD-L1 expression, and patient characteristics. Spearman's rank correlation was computed to observe the strength and direction of association among variables. Patient characteristics comparisons were made using chi-square test .06
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.
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r, correlation coefficient; P, calculated probability; LP, lamina propria; EDLF, epithelial dysplasia with lichenoid features. Statistically significant correlations are marked with bold.
any association between dysplasia grade and smoking. Further studies are needed to reveal the connection between gender and dysplasia grade.
We followed the disease progression of eight patients over different periods. In contrast to our hypothesis of progression in dysplasia grade and other analyzed parameters, no such pattern was F I G U R E 2 Fluctuation of dysplasia grade, inflammatory cell infiltration, and immune checkpoint expression over time. Eight of the studied patients were followed over different time intervals. The dysplasia grade (A), inflammatory cell infiltration (B), epithelium IDO1 expression (C), lamina propria IDO1 expression (D), and PD-L1-positive cell count (E) fluctuated over time. Each patient is presented in different colors detected. Instead, all studied parameters fluctuated over time. This result is consistent with previous observations that the progression of dysplasia in oral cavity might not be linear. 30 In conclusion, the present study demonstrated that the expression of IDO1 and PD-L1 are associated with the dysplasia grade and with inflammatory cell infiltration, which putatively indicates that these immune checkpoints might have a role in the progression of dysplasia. As this is an exploratory study, we have tried to look at many possible associations in the data. However, further specific studies are required to confirm any associations presented from the present study. The findings of the time series samples suggest that the progression pattern of dysplasia is not a liner process. Accordingly, the patients should be carefully followed regardless of the dysplasia grade.
